Meet your potential at one of the best places to work in CA, as awarded by Forbes and Newsweek.
Pemvidutide, a GLP-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and bodyweight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial
No, bruising is not listed as a common side effect in FDA prescribing information for semaglutide
Patients taking any of these medications along with semaglutide experience multiple simultaneous hits to b12 absorption
Once it's past its expiration date, the medication can begin to break down
While our weight loss program is fully available online for patients across West Virginia, customers are welcome to visit InjectCos premier med spa in Texas for additional medical-grade aesthetic services